Skip to main content
SpringerLink
Log in

Predictive Value of Baseline Neutrophil/Lymphocyte Ratio for T4 Disease in Wall-Penetrating Gastric Cancer

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Multimodality therapy has been used in the management of gastric cancer associated with locoregional spread. However, the accurate clinical staging still remains to be established. The neutrophil/lymphocyte ratio (NLR) in the peripheral blood is reported to be an easily assessable prognostic factor in cancer patients. We evaluated the predictive significance of the NLR and other serological parameters in patients with wall-penetrating gastric cancer.

Methods

Two hundred sixty-two patients who underwent gastric cancer surgery between 2002 and 2005 were identified retrospectively. Wall penetration was defined as wall invasion deeper than the muscularis propria (≥T2). Blood data were collected from routinely performed blood examinations before treatment and were analyzed with respect to T stage, nodal status, and histological features. A high NLR was defined as less than 3.2 based on ROC curve analysis, and the predictive value of a high NLR for T4 cancer was evaluated.

Results

Elevated levels of NLR (P = 0.004) and C-reactive protein (CRP) (P = 0.017) and the decrease in lymphocyte count (Lym, P = 0.032) and serum hemoglobin (Hb, P < 0.001) were correlated with the T stage, but there was no meaningful correlation with either positive nodal status or histological differentiation. With respect to the predictive value for stage T4, an elevated NLR (OR = 2.206, 95% CI = 1.187–4.100; P = 0.012), decrease of Hb (OR = 1.875, 95% CI = 1.005–3.500; P = 0.048), and poorly differentiated histology (OR = 3.134, 95% CI = 1.593–6.167; P = 0.001) were identified as independent predictive factors.

Conclusion

Our findings suggest that the preoperative values of the NLR may be reliable for predicting T4 disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E et al (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249

    Article  PubMed  Google Scholar 

  2. Noguchi Y, Yoshikawa T, Tsuburaya A et al (2000) Is gastric carcinoma different between Japan and the United States? Cancer 89:2237–2246

    Article  PubMed  CAS  Google Scholar 

  3. Maruyama K, Okabayashi K, Kinoshita T (1987) Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 11:418–425. doi:10.1007/BF01655804

    Article  PubMed  CAS  Google Scholar 

  4. Sakuramoto S, Sasako M, Yamaguchi T et al (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810–1820

    Article  PubMed  CAS  Google Scholar 

  5. Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20

    Article  PubMed  CAS  Google Scholar 

  6. Macdonald JS, Smalley SR, Benedetti J et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725–730

    Article  PubMed  CAS  Google Scholar 

  7. Brennan MF (2005) Current status of surgery for gastric cancer: a review. Gastric Cancer 8:64–70

    Article  PubMed  Google Scholar 

  8. Chen CY, Hsu JS, Wu DC et al (2007) Gastric cancer: preoperative local staging with 3D multi-detector row CT—correlation with surgical and histopathologic results. Radiology 242:472–482

    Article  PubMed  Google Scholar 

  9. Habermann CR, Weiss F, Riecken R et al (2004) Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology 230:465–471

    Article  PubMed  Google Scholar 

  10. Hwang SW, Lee DH, Lee SH et al (2010) Preoperative staging of gastric cancer by endoscopic ultrasonography and multidetector-row computed tomography. J Gastroenterol Hepatol 25:512–518

    Article  PubMed  Google Scholar 

  11. Kumano S, Murakami T, Kim T et al (2005) T staging of gastric cancer: role of multi-detector row CT. Radiology 237:961–966

    Article  PubMed  Google Scholar 

  12. de Graaf GW, Ayantunde AA, Parsons SL et al (2007) The role of staging laparoscopy in oesophagogastric cancers. Eur J Surg Oncol 33:988–992

    Article  PubMed  Google Scholar 

  13. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867

    Article  PubMed  CAS  Google Scholar 

  14. Mantovani A, Allavena P, Sica A et al (2008) Cancer-related inflammation. Nature 454:436–444

    Article  PubMed  CAS  Google Scholar 

  15. Aliustaoglu M, Bilici A, Ustaalioglu BB et al (2010) The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment. Med Oncol 27(4):1060–1065

    Article  PubMed  Google Scholar 

  16. Crumley AB, McMillan DC, McKernan M et al (2006) An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer 94:1568–1571

    PubMed  CAS  Google Scholar 

  17. Mohri Y, Tanaka K, Ohi M et al (2010) Prognostic significance of host- and tumor-related factors in patients with gastric cancer. World J Surg 34:285–290. doi:10.1007/s00268-009-0302-1

    Article  PubMed  Google Scholar 

  18. Ray-Coquard I, Cropet C, Van Glabbeke M et al (2009) Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res 69:5383–5391

    Article  PubMed  CAS  Google Scholar 

  19. Satomi A, Murakami S, Ishida K et al (1995) Significance of increased neutrophils in patients with advanced colorectal cancer. Acta Oncol 34:69–73

    Article  PubMed  CAS  Google Scholar 

  20. Shimada H, Takiguchi N, Kainuma O et al (2010) High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer 13:170–176

    Article  PubMed  Google Scholar 

  21. Ubukata H, Motohashi G, Tabuchi T et al (2010) Evaluations of interferon-gamma/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. J Surg Oncol 102(7):742–747

    Article  PubMed  Google Scholar 

  22. Yamanaka T, Matsumoto S, Teramukai S et al (2007) The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 73:215–220

    Article  PubMed  Google Scholar 

  23. Sobin LH, Wittekind C (eds) (2010) TMN Classification of Malignant Tumours (UICC). Wiley-Blackwell, Chichester, UK

    Google Scholar 

  24. Serhan CN, Brain SD, Buckley CD et al (2007) Resolution of inflammation: state of the art, definitions and terms. FASEB J 21:325–332

    Article  PubMed  CAS  Google Scholar 

  25. Eck M, Schmausser B, Scheller K et al (2003) Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma. Clin Exp Immunol 134:508–515

    Article  PubMed  CAS  Google Scholar 

  26. Coussens LM, Tinkle CL, Hanahan D et al (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103:481–490

    Article  PubMed  CAS  Google Scholar 

  27. Kido S, Kitadai Y, Hattori N et al (2001) Interleukin 8 and vascular endothelial growth factor—prognostic factors in human gastric carcinomas? Eur J Cancer 37:1482–1487

    Article  PubMed  CAS  Google Scholar 

  28. Yancopoulos GD, Davis S, Gale NW et al (2000) Vascular-specific growth factors and blood vessel formation. Nature 407:242–248

    Article  PubMed  CAS  Google Scholar 

  29. Crumley AB, Stuart RC, McKernan M et al (2008) Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-ps) in patients receiving palliative chemotherapy for gastroesophageal cancer. J Gastroenterol Hepatol 23:e325–e329

    Article  PubMed  CAS  Google Scholar 

  30. McMillan DC (2008) An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 67:257–262

    Article  PubMed  Google Scholar 

Download references

Disclosure

The authors have no conflicts of interest or financial ties to disclose.

Author information

Authors and Affiliations

  1. Department of Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Japan

    Masaki Aizawa, Naoto Gotohda, Shinichiro Takahashi, Masaru Konishi & Taira Kinoshita

Authors
  1. Masaki Aizawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naoto Gotohda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shinichiro Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masaru Konishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Taira Kinoshita
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masaki Aizawa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aizawa, M., Gotohda, N., Takahashi, S. et al. Predictive Value of Baseline Neutrophil/Lymphocyte Ratio for T4 Disease in Wall-Penetrating Gastric Cancer. World J Surg 35, 2717–2722 (2011). https://doi.org/10.1007/s00268-011-1269-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-011-1269-2

Keywords

Search

Navigation